Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia. Issue 4 (April 2014)

• Record Type: Journal Article
• Authors: Wiegering, Verena; Frank, Jana; Freudenberg, Sandra; Morbach, Henner; Schlegel, Paul G.; Eyrich, Matthias; Winkler, Beate
• Is Part Of: Leukemia & lymphoma. Volume 55:Issue 4(2014:Apr.)
• Page Start: 870
• Page End: 875
• Publication Date: 2014-04
• Subjects: Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.3109/10428194.2013.816423
• Languages: English
• ISSNs: 1042-8194

Abstract

<abstract> <title>Abstract</title> <p>Chemotherapy for childhood acute lymphoblastic leukemia (ALL) is a highly effective treatment, but at the same time causes significant suppression of the patient's immunity. Immune reconstitution was studied in a homogeneous cohort of 48 children with standard or medium risk ALL treated according to the ALL-Berlin–Frankfurt–Münster (BFM) protocol. Whereas the T-cell compartment was only moderately affected and recovered to normal levels quickly after treatment cessation, B-cells were significantly reduced during and after therapy. In particular, the naive B-cell compartment declined. Even 5 years after the end of therapy, B-cell distribution was disturbed and patients showed an ongoing reconstitution. Thus, even standard regimens for chemotherapy cause severe B-cell depletion that resolves only gradually.</p> </abstract>